Zymtronix Patents – Key Insights and Stats

Zymtronix has a total of 29 patents globally, out of which 2 have been granted. Of these 9171 patents, more than 89% patents are active. The United States of America is where Zymtronix has filed the maximum number of patents, followed by Canada and Europe. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Zymtronix.

Zymtronix was founded in 2013. Zymtronix develops technology for enzyme immobilization. It provides a platform to immobilize enzymes and screen for immobilized enzyme performance. New materials and customer-oriented processes for small molecule conversion are part of the company’s development. The company is aiming to create sustainable and responsible processes for high-performance biocatalysis.

Do read about some of the most popular patents of Zymtronix which have been covered by us in this article and also you can find Zymtronix patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Zymtronix patent portfolio.

How many patents does the Founder and CEO of Zymtronix have?

The Founder and CEO Stephane Corgie have 58 patents and the co-founder and CEO Juan Diego Alonso has 0 patents.

How many patents does Zymtronix have?

Zymtronix has a total of 29 patents globally. These patents belong to 7 unique patent families. Out of 29 patents, 26 patents are active.

How Many Patents did Zymtronix File Every Year?

Zymtronix Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantZymtronix Applications FiledZymtronix Patents Granted
201714
201914
202112

How many Zymtronix patents are Alive/Dead?

Worldwide Patents

Zymtronix Patents Portfolio

How Many Patents did Zymtronix File in Different Countries?

Zymtronix Worldwide Patents

Countries in which Zymtronix Filed Patents

CountryPatents
United States Of America6
Canada5
Europe5
China4
Japan4
India1

Where are Research Centers of Zymtronix Patents Located?

The research center of all the Zynmtronix patents is the United States of America.

What Percentage of Zymtronix US Patent Applications were Granted?

Zymtronix (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Zymtronix patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Zymtronix?

Law FirmTotal ApplicationsSuccess Rate
Jonathan M Kaplan8100.00%

List of Zymtronix Patents –

Publication NumberTitle
US10993436B2Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
US20210275997A9Magnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalysts
US20210263001A1Immobilized Enzymes And Microsomes On Magnetic Scaffolds
US20210189374A1Printable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilization
US20200061597A1Magnetically Immobilized Metabolic Enzymes And Cofactor Systems
US20190174746A1Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
EP3856900A4Printable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilization
EP3846938A4Immobilized Enzymes And Microsomes On Magnetic Scaffolds
EP3548175A4Magnetically Immobilized Metabolic Enzymes And Cofactor Systems
EP3496539A4Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
EP3442341A4Magnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalysts
CN113166749APrintable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilization
CN112805091AImmobilized Enzymes And Microsomes On Magnetic Scaffolds
CN109788762AMagnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
CN109068659AMagnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalysts
WO2022119982A3Modular Glycan Production With Immobilized Bionanocatalysts
WO2020069227A1Printable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilization
WO2020051159A1Immobilized Enzymes And Microsomes On Magnetic Scaffolds
WO2018102319A1Magnetically Immobilized Metabolic Enzymes And Cofactor Systems
CA3114353A1Printable Magnetic Powders And 3D Printed Objects For Bionanocatalyst Immobilization
CA3111104A1Immobilized Enzymes And Microsomes On Magnetic Scaffolds
CA3045640A1Magnetically Immobilized Metabolic Enzymes And Cofactor Systems
CA3031802A1Magnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
CA3020916A1Magnetic Macroporous Polymeric Hybrid Scaffolds For Immobilizing Bionanocatalysts
IN201937001779AMagnetically Immobilized Biocidal Enzymes And Biocidal Chemicals
JP7082108B2Magnetic Macroporous Polymer Hybrid Scaffolding For Bio-Nanocatalyst Immobilization
JP2022500067APrintable Magnetic Powder And 3D Printed Objects For Biomananocatalytic Immobilization
JP2022500016AImmobilized Oxygen And Microsomes On Magnetic Scaffolds
JP2020500532AMagnetically Immobilized Metabolic Enzymes And Cofactor Systems

EXCLUSIVE INSIGHTS COMING SOON!

What are Zymtronix key innovation segments?

What Technologies are Covered by Zymtronix?

The chart below distributes patents filed by Zymtronix in different countries on the basis of the technology protected in patents. It also represents the markets where Zymtronix thinks it’s important to protect particular technology inventions.

R&D Focus: How has Zymtronix search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Zymtronix?

Related Articles

Five AI Patents – Insights & Stats (Updated 2024)

Five AI has a total of 480 patents globally, out of which 38 have been granted. Of these 480 patents, more than 55% patents are active. United Kingdom is where Five AI has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, United

Read More »

Dynaset Patents – Insights & Stats (Updated 2024)

Dynaset has a total of 23 patents globally, out of which 13 have been granted. Of these 23 patents, more than 65% patents are active. Finland is where Dynaset has filed the maximum number of patents, followed by Europe (EPO) and Germany. Parallelly, Finland seems to be the main focused

Read More »

HCA Healthcare Subsidiaries & Acquisitions

HCA Healthcare, a leading U.S. healthcare provider, has expanded through strategic acquisitions in areas like physician practices, urgent care, and healthcare technology. These moves have strengthened its ability to offer comprehensive services and improve efficiency, allowing the company to better meet the evolving needs of the healthcare industry. Notable Acquisitions

Read More »

Was this article helpful?

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.